Surprising new roles discovered for known blood cancer gene DNMT3A

A gene called DNMT3A is important for guiding blood stem cells into forming all the cell types present in blood, including red blood cells, white blood cells and platelets. When this gene accumulates mutations—which might occur with age or due to environmental exposures such as smoking—a person’s risk of developing blood cancers such as acute myeloid leukemia (AML) increases.
Read More

Research exposes far-reaching toll of financial hardship on patients with cancer

When someone mentions the word “toxicity” in relation to cancer treatment, they’re usually referring to the negative physical side effects and complications that can result from therapies like radiation and chemotherapy. But researchers at the University of Chicago Medicine are raising awareness of another kind of toxicity patients face: financial toxicity, which refers to the stress, expense and instability caused by direct and indirect costs associated with health care.
Read More

Algorithm reconstructs evolution and clinical progression of tumors to peer inside cancer’s ‘black box’

An international team led by the Clínic-IDIBAPS-UB along with the Institute of Cancer Research, London, has developed a new method based on DNA methylation to decipher the origin and evolution of cancer, which makes it possible to predict its future clinical course. The study, published today in the journal Nature, analyzes the evolution of the tumors of 2,000 patients with leukemias and lymphomas.
Read More

How small cell lung cancer hijacks neuronal synapses

An international research team has shown that lung cancer cells can form functional synapses with neurons, effectively hijacking the body’s neural circuits to grow faster. The finding reveals a startling new dimension of cancer biology and opens promising new avenues for therapies against this disease. The study titled “Functional synapses between neurons and small-cell lung cancer” is published in Nature.
Read More

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

A major UK study has provided the most comprehensive analysis to date of a cancer diagnosis pathway for patients presenting with non-specific symptoms (NSS), such as unexplained weight loss or fatigue. These symptoms can indicate a wide range of conditions, from benign diseases to late-stage cancers, making timely and accurate diagnosis a significant challenge in primary care.
Read More
Top